Medical specialists from France tagged as investigators in clinical trials studying Melanoma
Total 278 results
-
Celeste Lebbe, MD, PhDSeen in:
- Paris, Assistance Publique - Hôpitaux de Paris (AP-HP), Hopital Saint-Louis, centre d'oncodermatologie
- Paris, Hopital St Louis
Trials:- NCT02828202 (Principal Investigator)
- NCT02799901 (Principal Investigator)
Conditions: -
Charlee Nardin, Dr.Seen in:
- Besancon, Centre Hospitalier Universitaire de Besançon Jean Minjoz
- Besançon, CHU de Besançon
Trials:- NCT05155254 (Principal Investigator)
- NCT02828202 (Sub-Investigator)
Conditions: -
Christine Longvert, MDSeen in:
- Boulogne-Billancourt, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Ambroise Paré
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Christophe Bedane, Pr.Seen in:
- Limoges, CHU de Limoges - Hôpital Dupuytren
Trials:- NCT03235245 (Principal Investigator)
Conditions: -
Christophe SAJOUS, MDSeen in:
- Bron, Groupement hospitalier Est - Multidisciplinary oncological platform
- Pierre-Bénite, Centre Hospitalier Lyon Sud - Department of Medical Oncology
Trials:- NCT04605146 (Principal Investigator)
Conditions: -
Claire Abasq, MDSeen in:
- Brest, CHU de Brest
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Clara FONTAINE-DELARUELLE, MDSeen in:
- Pierre-Bénite, Hôpital Lyon Sud - Department of pneumology,Thoracic oncology
Trials:- NCT04605146 (Sub-Investigator)
Conditions: -
Claudia Bejar, MDSeen in:
- Bobigny, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Avicennes
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Coralie Zumelzu, MDSeen in:
- Bobigny, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Avicennes
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Daphne Bosset, MDSeen in:
- Boulogne-Billancourt, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Ambroise Paré
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
David Planchard, MDSeen in:
- Villejuif, Gustave Roussy
Trials:- NCT04913285 (Principal Investigator)
Conditions: -
Delphine BORCHIELLINI, MDSeen in:
- AM, Nice Cedex 2, Centre Antoine-Lacassagne
- Nice, Centre Antoine Lacassagne
Trials:- NCT05551117 (Principal Investigator)
- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Urothelial Carcinoma;
- Papillary Renal Cell Carcinoma Type 2
-
Delphine Legoupil, MDSeen in:
- Brest, CHU de Brest
Trials:- NCT02828202 (Principal Investigator)
Conditions: -
Denis Chatelain, MDSeen in:
- Amiens, CHU d'Amiens
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Denis MAILLET, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud - Department of Medical Oncology
Trials:- NCT04605146 (Principal Investigator)
Conditions: -
Dereure Olivier, PhDSeen in:
- Herault, Montpellier, CHU Montpellier, Dermatologie
- Occitanie, Montpellier, CHU de Montpellier
Trials:- NCT05649683 (Sub-Investigator)
- NCT04563923 (Sub-Investigator)
Conditions: -
Diego Tosi, MDSeen in:
- Herault, Montpellier, Institut Regional du Cancer de Montpellier - ICM Val d'Aurelle
- Montpellier, ICM - Montpellier
Trials:- NCT05551117 (Principal Investigator)
- NCT05828459 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Solid Tumor;
- Hematological Malignancy
-
Dominique Deplanque, MD, PhDSeen in:
- Lille, CHRU de Lille
Trials:- NCT02828202 (Principal Investigator)
Conditions: -
Dominique Figarella-Branger, MD, PhDSeen in:
- Marseille, AP-HM Hopital de la Timone
Trials:- NCT02828202 (Principal Investigator)
Conditions: -
Dr CassierSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04725331 (Principal Investigator)
-
Dr ChampiatSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT04725331 (Principal Investigator)
-
E Melgar, MDSeen in:
- Nancy, CHU de Nancy
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Elisa FUNCK-BRENTANOSeen in:
- Paris, APHP- Ambroise Paré
Trials:- NCT05429138 (Sub-Investigator)
Conditions: -
Elodie ARCHIERSeen in:
- Marseille, Hôpital Saint-Joseph
Trials:- NCT05429138 (Sub-Investigator)
Conditions: -
Emilie Brenaut, MDSeen in:
- Brest, CHU de Brest
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Emilie Gerard, MDSeen in:
- Bordeaux, CHU de Bordeaux Hôpital Saint-André
Trials:- NCT02828202 (Sub-Investigator)
Conditions: -
Emmanuelle COUTY, MDSeen in:
- Saint-Étienne, University hospital of Saint-Etienne - Department of dermatology
Trials:- NCT04605146 (Principal Investigator)
Conditions:
Clinical Trials on Melanoma
-
H. Lee Moffitt Cancer Center and Research InstituteTurnstone Biologics, Corp.RecruitingMetastatic Melanoma | Conjunctival Melanoma | Ocular Melanoma | Unresectable Melanoma | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Iris Melanoma | Acral Melanoma | Non-Cutaneous MelanomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IA Melanoma | Stage IB Melanoma | Stage IIA MelanomaUnited States
-
MelanomaPRO, RussiaRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma, Stage II | Melanoma, Uveal | Melanoma in Situ | Melanoma, OcularRussian Federation
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of VirginiaCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin Melanoma | Stage 0 Skin Melanoma | Stage I Skin Melanoma | Stage II Skin MelanomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIB Melanoma | Stage IIC MelanomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IV Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage...United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
-
Emory UniversityGenentech, Inc.Active, not recruitingStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States